⌘K

Login Start Free

Home/Filings/4/0001209191-15-081660

4//SEC Filing

NEKTAR THERAPEUTICS 4

Accession 0001209191-15-081660

$NKTRCIK 0000906709operating

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:27 PM ET

Size

30.9 KB

Accession

0001209191-15-081660

Insider Transaction Report

Form 4

Period: 2015-11-18

NEKTAR THERAPEUTICSNKTR

Director

Transactions

Sale
Common Stock
2015-11-19$15.02/sh−15,128$227,223→ 20,000 total
Exercise/Conversion
Common Stock
2015-11-18$8.37/sh+15,000$125,550→ 35,000 total
Sale
Common Stock
2015-11-18$15.00/sh−15,000$225,000→ 20,000 total
Exercise/Conversion
Common Stock
2015-11-18$5.14/sh+5,372$27,612→ 25,372 total
Exercise/Conversion
Common Stock
2015-11-19$5.14/sh+15,128$77,758→ 35,128 total
Exercise/Conversion
Common Stock
2015-11-20$5.14/sh+9,500$48,830→ 29,500 total
Exercise/Conversion
Stock Option
2015-11-19−15,128→ 9,500 total
Exercise: $5.14From: 2012-09-30Exp: 2019-09-12→ Common Stock (15,128 underlying)
Exercise/Conversion
Stock Opion
2015-11-20−40,000→ 0 total
Exercise: $9.24From: 2013-09-30Exp: 2020-09-13→ Common Stock (40,000 underlying)
Sale
Common Stock
2015-11-18$15.00/sh−5,372$80,580→ 20,000 total
Sale
Common Stock
2015-11-20$15.02/sh−9,500$142,690→ 20,000 total
Exercise/Conversion
Common Stock
2015-11-20$9.24/sh+40,000$369,600→ 60,000 total
Sale
Common Stock
2015-11-20$15.02/sh−40,000$600,800→ 20,000 total
Exercise/Conversion
Stock Option
2015-11-18−15,000→ 0 total
Exercise: $8.37From: 2010-09-30Exp: 2017-09-14→ Common Stock (15,000 underlying)
Exercise/Conversion
Stock Option
2015-11-18−5,372→ 24,628 total
Exercise: $5.14From: 2012-09-30Exp: 2019-09-12→ Common Stock (5,372 underlying)
Exercise/Conversion
Stock Option
2015-11-20−9,500→ 0 total
Exercise: $5.14From: 2012-09-30Exp: 2019-09-12→ Common Stock (9,500 underlying)

Footnotes (3)

[F1]This transaction was made pursuant to a Rule 10b5-1 trading plan.
[F2]This transaction was executed in multiple trades at prices ranging from $15.00 to $15.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
[F3]This transaction was executed in multiple trades at prices ranging from $15.00 to $15.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000906709

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 5:27 PM ET
Size: 30.9 KB

View on SEC.gov